Correlation Between Recursion Pharmaceuticals and Sprott Focus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Sprott Focus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Sprott Focus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and Sprott Focus Trust, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Sprott Focus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Sprott Focus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Sprott Focus.

Diversification Opportunities for Recursion Pharmaceuticals and Sprott Focus

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Recursion and Sprott is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Sprott Focus Trust in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sprott Focus Trust and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Sprott Focus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sprott Focus Trust has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Sprott Focus go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and Sprott Focus

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 7.19 times more return on investment than Sprott Focus. However, Recursion Pharmaceuticals is 7.19 times more volatile than Sprott Focus Trust. It trades about 0.06 of its potential returns per unit of risk. Sprott Focus Trust is currently generating about 0.11 per unit of risk. If you would invest  672.00  in Recursion Pharmaceuticals on September 13, 2024 and sell it today you would earn a total of  64.00  from holding Recursion Pharmaceuticals or generate 9.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Recursion Pharmaceuticals  vs.  Sprott Focus Trust

 Performance 
       Timeline  
Recursion Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Sprott Focus Trust 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Sprott Focus Trust are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Sprott Focus may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Recursion Pharmaceuticals and Sprott Focus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Recursion Pharmaceuticals and Sprott Focus

The main advantage of trading using opposite Recursion Pharmaceuticals and Sprott Focus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Sprott Focus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sprott Focus will offset losses from the drop in Sprott Focus' long position.
The idea behind Recursion Pharmaceuticals and Sprott Focus Trust pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stocks Directory
Find actively traded stocks across global markets